Keryx gains U.S. approval for kidney dialysis drug, plans launch by end of year

A biotech company with a fast-growing presence in Boston, Keryx Biopharmaceuticals, has joined the ranks of commercial stage drug companies with U...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.